Regulation of macrophage activation and inflammation by spermine: A new chapter in an old story

Critical Care Medicine

Volumn 28, Issue 4 SUPPL., 2000, Pages

  Zhang, Minghuang ^a   Wang, Haichao ^a   Tracey, Kevin J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokines; Inflammation; Macrophage; Nitric oxide; Polyamines; Spermine; Tumor necrosis factor

Indexed keywords

ACUTE PHASE PROTEIN; POLYAMINE; SPERMINE;

CELL DAMAGE; CELL DEATH; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REGENERATION;

EID: 0034097797     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004001-00007     Document Type: Review

References (92)

1. Tracey KJ: Tumor necrosis factor (cachetin) in the biology of septic shock syndrome. Circ Shock 1991; 35:123-128
2. Zhang M, Tracey KJ: Tumor necrosis factor. In: The Cytokine Handbook. Third Edition. Thomson AW (Ed). London, Academic Press Limited, 1998, pp 517-548
3. Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998; 16:457-499
4. Nathan C: Natural resistance and nitric oxide. Cell 1995; 82:873-876
5. Fenton MJ, Golenbock DT: LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 25-32
6. Glauser MP: The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 1996; 52(Suppl 2):9-17
7. Tracey KJ, Fong Y, Hesse DG, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474
8. Cabrera M, Shaw MA, Sharples C, et al: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264
9. McGuire W, Hill AV, Allsopp CE, et al: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510
10. Auphan N, Di Donato JA, Rosette C, et al: Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270:286-290
11. Scheinman RI, Cogswell PC, Lofquist AK, et al: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286
12. Tsunawaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260-262
13. Kulkarni AB, Huh CG, Becker D, et al: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993; 90: 770-774
14. Howard M, Muchamuel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208
15. Gerard C, Bruyns C, Marchant A, et al: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547-550
16. 2. J Exp Med 1994; 180:2365-2370
17. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355-1364
18. Leuwenhoek AV: Observations D Anthonii Leuwenhoek de natis e semine genitali animalculis. Phil Trans 1678; 12:1040-1043
19. Dudley HW, Rosenheim O, Starling WW: The chemical constitution of spermine. III. Structure and synthesis. Biochem J 1926; 20:1082-1094
20. Brieger I: Uberdie aromatischen Produkte der Faulniss aus Eiweiss. Z Physiol Chem 1879; 3: 134-148
21. Dudley HW, Rosenheim O, Starling WW: The constitution and synthesis of spermidine, a newly discovered base isolated from animal tissues. Biochem J 1927; 21:97-103
22. Morgan DM: Polyamines. An introduction. Methods Mol Biol 1998; 79:3-30
23. Tabor CW, Tabor H: Polyamines in microorganisms. Microbiol Rev 1985; 49:81-99
24. Pegg AE, Shuttleworth K, Hibasami H: Specificity of mammalian spermidine synthase and spermine synthase. Biochem J 1981; 197:315-320
25. Casero RAJ, Pegg AE: Spermidine/spermine N1-acetyltransferase-The turning point in polyamine metabolism. FASEB J 1993; 7:653-661
26. Seiler N, Bolkenius FN, Rennert OM: Interconversion, catabolism and elimination of the polyamines. Med Biol 1981; 59:334-346
27. Seiler N, Atanassov CL, Raul F: Polyamine metabolism as target for cancer chemoprevention. Int J Oncol 1998; 13:993-1006
28. Bardocz S: The role of dietary polyamines. Eur J Clin Nutr 1993; 47:683-690
29. Seiler N, Dezeure F: Polyamine transport in mammalian cells. Int J Biochem 1990; 22: 211-218
30. Zhang M, Borovikova L, Wang H, et al: Spermine inhibition of monocyte activation and inflammation. Mol Med 1999; 5:595-605
31. Seiler N, Delcros JG, Moulinoux JP: Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 1996; 28: 843-861
32. Kramer DL, Miller JT, Bergeron RJ, et al: Regulation of polyamine transport by polyamines and polyamine analogs. J Cell Physiol 1993; 155: 399-407
33. Sakata K, Fukuchi-Shimogori T, Kashiwagi K, et al: Identification of regulatory region of antizyme necessary for the negative regulation of polyaminetransport. Biochem Biophys Res Commun 1997; 238:415-419
34. Mitchell JL, Judd GG, Bareyal-Leyser A, et al: Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. Biochem J 1994; 299: 19-22
35. Li X, Coffino P: Degradation of ornithine decarboxylase: Exposure of the C-terminal target by a polyamine-inducible inhibitory protein. MolCell Biol 1993; 13:2377-2383
36. Gaugas JM: Polyamines in biomedical research. In: Polyamines in Biomedical Research. Gaugas JM (Ed). Chichester, UK, John Wiley & Sons, 1980
37. Hirsch JG, Dubos RJ: The effect of spermine on tubercle bacilli. J Exp Med 1952; 95: 191-208
38. Colombatto S, De Agostini M, Corsi D, et al: Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol Chem Hoppe Seyler 1989; 370:745-748
39. Clarke JR, Tyms AS: Polyamine biosynthesis in cells infected with different clinical isolates of human cytomegalovirus. J Med Virol 1991; 34:212-216
40. Wickstrom K: Polyamines in rabbit aqueous humor after surgical trauma to the eye. Curr Eye Res 1991; 10:463-469
41. Cipolla B, Guille F, Moulinoux JP, et al: Polyamines and prostatic carcinoma: Clinical and therapeutic implications. Eur Urol 1993; 24: 124-131
42. Colella G, Cianciulli S, De Santis A, et al: [The determination of polyamines in tumors of the maxillofacial area] [Dosaggio delle poliamine nei tumori della regione maxillofacciale.]. Minerva Stomatol 1994; 43: 133-136
43. Furumitsu Y, Yukioka K, Kojima A, et al: Levels of urinary polyamines in patients with rheumatoid arthritis. J Rheumatol 1993; 20: 1661-1665
44. Yukioka K, Wakitani S, Yukioka M, et al: Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis. J Rheumatol 1992; 19:689-692
45. Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35:55-91
46. Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986; 234:249-262
47. Brune B, Hartzell P, Nicotera P, et al: Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp Cell Res 1991; 195:323-329
48. Feuerstein BG, Pattabiraman N, Marton LJ: Molecular mechanics of the interactions of spermine with DNA: DNA bending as a result of ligand binding. Nucleic Acids Res 1990; 18:1271-1282
49. Snyder RD: Polyamine depletion is associated with altered chromatin structure in HeLa cells. Biochem J 1989; 260:697-704
50. Ha HC, Sirisoma NS, Kuppusamy P, et al: The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci U S A 1998; 95:11140-11145
51. Shiloh MU, MacMicking JD, Nicholson S, et al: Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999; 10:29-38
52. Fidelus RK, Laughter AH, Twomey JJ: The role of mitogens and lymphokines in the induction of omithine decarboxylase (ODC) in T lymphocytes. J Immunol 1984; 132: 1462-1465
53. Scott IG, Poso H, Akerman KE, et al: Rapid activation of ornithine decarboxylase by mitogenic (but not by nonmitogenic) ligands in human T lymphocytes. Eur J Immunol 1985; 15:783-787
54. Bowlin TL, McKown BJ, Sunkara PS: Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction. Cell Immunol 1987; 105:110-117
55. Pasquali JL, Mamont PS, Weryha A, et al: Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine an inhibitor of polyamine synthesis: I. Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes. Clin Exp Immunol 1988; 72:141-144
56. Messina L, Spampinato G, Arcidiacono A, et al: Polyamine involvement in functional activation of human macrophages. J Leukoc Biol 1992; 52:585-587
57. Kaczmarek L, Kaminska B, Messina L, et al: Inhibitors of polyamine biosynthesis block tumor necrosis factor-induced activation of macrophages. Cancer Res 1992; 52: 1891-1894
58. Mozhenok TP, Bulychev AG, Braun AD: [The effect of polyamines on lysosome fusion with phagosomes in mouse peritoneal macrophages] [Vliianie poliaminov na sliianie lizosom s fagosomami v peritoneal'nykh makrofagakh myshei]. Tsitologiia 1990; 32: 882-887
59. Byrd WJ, Jacobs DM, Amoss MS: Synthetic polyamines added to cultures containing bovine sera reversibly inhibit in vitro parameters of immunity. Nature 1977; 267:621-623
60. Ferrante A, Maxwell GM, Rencis VO, et al: Inhibition of the respiratory burst of human neutrophils by the polyamine oxidase-polyamine system. Int J Immunopharmacol 1986; 8:411-417
61. Quemener V, Blanchard Y, Chamaillard L, et al: Polyamine deprivation: a new tool in cancer treatment. Anticancer Res 1994; 14: 443-448
62. Szabo C, Southan GJ, Wood E, et al: Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: Requirement of a serum factor. Br J Pharmacol 1994; 112:355-356
63. Labib RS, Tomasi TBJ: Enzymatic oxidation of polyamines. Relationship to immunosuppressive properties. Eur J Immunol 1981; 11:266-269
64. Bianchi M, Bloom O, Raabe T, et al: Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996; 183:927-936
65. Zhang M, Caragine T, Wang H, et al: Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: A counterregulatory mechanism that restrains the immune response. J Exp Med 1997; 185: 1759-1768
66. Baydoun AR, Morgan DM: Inhibition of omithine decarboxylase potentiates nitric oxide production in LPS-activated J774 cells. Br J Pharmacol 1998; 125:1511-1516
67. Bowlin TL, Hoeper BJ, Rosenberger AL, et al: Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice. Cancer Res 1990; 50:4510-4514
68. Zhang M, Caragine T, Wang H, et al: Polyamines as endogenous inhibitors of proinflammatory cytokine synthesis. Surg Forum 1997; XLVIII:60-62
69. Wang H, Zhang M, Soda K, et al: Fetuin protects the fetus from TNF. Lancet 1997; 350:861-862
70. Fujiwara K, Bai G, Kitagawa T, Tsuru D: Immunoelectron microscopic study for polyamines. J Histochem Cytochem 1998; 46: 1321-1328.
71. Rindani TH: Recovery of an anti-inflammatory fraction from inflammatory exudate. Indian J Med Res 1956; 44:673-676
72. Hempel KH, Fernandez LA, Persellin RH: Effect of pregnancy sera on isolated lysosomes. Nature 1970; 225:955-956
73. Capstick RB, Lewis DA, Cosh JA: Naturally occurring anti-inflammatory factors in the synovial fluids of patients with rheumatic disease and their possible mode of action. Ann Rheum Dis 1975; 34:213-218
74. Billingham ME, Robinson BV, Robson JM: Partial purification of the anti-inflammatory factor(s) in inflammatory exudate. Br J Pharmacol 1969; 35:543-557
75. Persellin RH: Lysosome stabilization by adjuvant arthritis serum. Arthritis Rheum 1972; 15:144-152
76. Pinals RS: Effect of hepatic injury on adjuvant arthritis. Ann Rheum Dis 1973; 32: 471-474
77. Oyanagui Y: Anti-inflammatory effects of polyamines in serotonin and carrageenan paw edemata-possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radical. Agents Actions 1984; 14:228-237
78. ter Steege JC, Forget PP, Buurman WA: Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model. Shock 1999; 11:115-119
79. Seiler N, Atanassov CL: The natural polyamines and the immune system. Prog Drug Res 1994; 43:87-141
80. Kanof ME, Rance NE, Hamilton SR, et al: Congenital diarrhea with intestinal inflammation and epithelial immaturity. J Pediatr Gastroenterol Nutr 1987; 6:141-146
81. Elgert KD, Alleva DG, Mullins DW: Tumor-induced immune dysfunction: The macrophage connection. J Leukoc Biol 1998; 64: 275-290
82. Taylor KA: Immune responses of cattle to African trypanosomes: Protective or pathogenic? Int J Parasitol 1998; 28:219-240
83. Faist E, Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20:454-459
84. Faist E: The mechanisms of host defense dysfunction following shock and trauma. Curr Top Microbiol Immunol 1996; 216: 259-274
85. Brown WM, Saunders NR, Mollgard K, et al: Fetuin - An old friend revisited. Bioessays 1992; 14:749-755
86. Stockert RJ: The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 1995; 75: 591-609
87. Dziegielewska KM, Brown WM, Gould CC, et al: Fetuin: An acute phase protein in cattle. J Comp Physiol 1992; 162:168-171
88. Clark DA, Delcros JG, Craft I: High levels of spermine in FVF medium as a negative predictor of subsequent success of embryo transfer. J Assist Reprod Genet 1996; 13: 464-467
89. Morgan DM, Illei G: Polyamine-polyamine oxidase interaction: part of maternal protective mechanism against fetal rejection. Br Med J 1980; 280:1295-1297
90. Romero R, Manogue KR, Mitchell MD, et al: Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Cynecol 1989; 161:336-341
91. Dziegielewska KM, Andersen NA: The fetal glycoprotein, fetuin, counteracts ill-effects of the bacterial endotoxin, lipopolysaccharide, in pregnancy. Biol Neonate 1998; 74: 372-375
92. Jahnen-Dechent W, Schinke T, Trindl A, et al: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997; 272: 31496-31503